CytoDyn CYDY
OTC CYDY
$0.20 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

CytoDyn (CYDY) Asset Utilization Ratio (2021 - 2022)

Updated

CytoDyn's (CYDY) Asset Utilization Ratio was 0.00 for fiscal Q4 2022 (quarter ended May 31, 2022), up 81.0% from the prior quarter.

Analysis

CytoDyn (CYDY) Asset Utilization Ratio (2021 - 2022) Analysis & Trends

Dating back to fiscal Q1 2022, CytoDyn's Asset Utilization Ratio record includes 4 quarters.

  • Per Business Quant data, the three fiscal quarters before Q4 2022 came in at 0.00 (Q3 2022), 0.00 (Q2 2022) and 0.00 (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 0.49
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 0.47
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 0.52
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 0.44
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 0.53
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 0.40
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 0.58
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 0.47
10 CytoDyn 274.70 Mn 274.70 Mn - -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2022 0.00
Feb 28, 2022 0.00
Nov 30, 2021 0.00
Aug 31, 2021 0.00
API Access

CytoDyn Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=CYDY&period=max&api_key=YOUR_API_KEY